Status:
COMPLETED
Axillary Reverse Mapping Using Methylene Blue Subcutaneous Injection Can Identify Arm Lymph Nodes and Vessels, Measuring Arm Size for Lymphedema, Histopathological Examination of Arm Lymph Nodes Included With Axillary Lymph Node Dissection
Lead Sponsor:
Zagazig University
Conditions:
Arm Lymphedema
Lymphatic Spread of Breast Cancer
Eligibility:
FEMALE
18+ years
Phase:
NA
Brief Summary
study patients; axillary node negative breast cancer female, 74 patients randomly allocated in two groups each 37 patients , group I , where axillary reverse mapping(ARM) +ve nodes were preserved and ...
Detailed Description
This study is comparative clinical trial carried out in the period between February 2015 and August 2019 on 74 female patients with early breast cancer. All patients were informed and signed a written...
Eligibility Criteria
Inclusion
- clinically free breast cancer
- sentinle LN positive
Exclusion
- patients on chemotherapy for breast cancer
- recurrent cases after conservative breast surgery
- bilateral disease and pregnant cases
Key Trial Info
Start Date :
February 1 2015
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 1 2019
Estimated Enrollment :
74 Patients enrolled
Trial Details
Trial ID
NCT04137744
Start Date
February 1 2015
End Date
August 1 2019
Last Update
November 6 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Zagazig Faculty of Medicine
Zagazig, Sharqya, Egypt, 44519